Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Louisiana for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Louisiana only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Louisiana (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Enrique Mendez (NPI 1174605646)

Field	Value
Entity Type	Individual
Organization	Enrique Mendez
Address	1727 Imperial Blvd Bldg 1b
City	Lake Charles
State	LA
ZIP	70605
Taxonomy	Rheumatology Physician
NPI Enumerated	October 20, 2006

Payer Source	Total Paid
Medicare	$1.1M
Medicaid	$0

Key Findings

This provider’s lifetime billing is effectively single‑payer: Total Medicare revenue is $1.1M and there is none (no Medicaid billing on file), so Medicare accounts for the entirety of reported public‑payer activity. Analysts should treat the profile as Medicare‑centric when assessing payer mix and revenue drivers.

Revenue is highly concentrated in a small set of services: the precomputed top 3 Medicare codes account for 55.4% of total Medicare revenue, driven by J0129 (21.8%, $236.3K), 99214 (21.2%, $229.6K), and J1306 (12.5%, $135.5K). These three codes together explain most of the provider’s Medicare dollars and should be the focus for revenue‑impact modeling.

The code mix is consistent with a rheumatology practice that delivers physician‑supervised biologic injections and office‑based evaluation and management. High‑revenue drug administration codes such as J0129 (abatacept), J1602 (golimumab IV), J0897 (denosumab), and J3111 (romosozumab) alongside infusion/administration procedure codes (96365, 96372) indicate in‑office administration of biologics as a core service line.

The provider reports sustained chronic care management activity: 99426 (95th percentile; typical, unremarkable volume), 99427 (94th percentile; typical, unremarkable volume) and G0506 (91th percentile; typical, unremarkable volume) appear in the top code list, signaling use of delegated clinical staff time and formal care‑planning services for complex chronic patients. This pattern aligns with ongoing longitudinal management rather than episodic, one‑off encounters.

There are notable statistical outliers and above‑typical volumes in specific codes. 99214 is an extreme outlier (rank #435 of 479517, 100th percentile; extreme outlier, far above typical national volume), reflecting very high volume of moderate‑complexity established visits, while 96372 is labeled as notably above typical national volume (rank #1831 of 58224, 97th percentile), indicating frequent use of independent injection services. These flags suggest visit throughput and routine injection procedures are important operational drivers.

Despite the large share of revenue from biologic drugs, the provider is not a dominant national administrator of those agents: J0129 ranks #727 of 1221 (40th percentile; typical, unremarkable volume) and J1306 ranks #104 of 462 (77th percentile; typical, unremarkable volume). In other words, biologic administration is a major revenue source for this clinician locally but their national ranks place them as a modest participant rather than a national leader for most drug codes.

The provider shows above‑typical billing for higher‑complexity and value codes beyond routine visits: 99205 (rank #4730 of 66257, 93th percentile; typical, unremarkable volume) and 99215 (rank #13016 of 145531, 91th percentile; typical, unremarkable volume) both appear, indicating the practice also captures higher‑intensity new and established patient encounters. Combined with the chronic care codes, this suggests a mixed portfolio of high‑touch new‑patient evaluations and ongoing complex care.

Operationally, this profile — long tenure (NPI enumerated: 2006-10-20 (~20 years ago)), heavy dependence on a few high‑revenue codes, and concentration in physician‑supervised biologic administration and high‑volume E/M — implies revenue sensitivity to changes in biologic utilization patterns, E/M reimbursement, or clinical staffing. For payer negotiations or partnership decisions, analysts should prioritize the top codes and chronic care services when estimating revenue impact of policy or formulary shifts.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

28 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	6,950	$30	$236.3K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	2,640	$90	$229.6K
J1306	Injection, inclisiran, 1 mg	15,050	$10	$135.5K
J3111	Injection, romosozumab-aqqg, 1 mg	15,750	$10	$126K
J1602	Injection, golimumab, 1 mg, for intravenous use	10,500	$10	$105K
J0897	Injection, denosumab, 1 mg	5,940	$20	$101K
99426	Clinical staff members, directed by a physician or other qualified healthcare professional, perform management and care plan services for a patient with a complex chronic condition, expected to last…	670	$50	$30.7K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	190	$120	$22.4K
99427	Clinical staff members, directed by a physician or other qualified healthcare professional, perform management and care plan services for a patient with a complex chronic condition, expected to last…	410	$40	$14.3K
99205	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider…	90	$150	$12.7K

Showing 1–10 of 28

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 28 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Louisiana Distribution

Enrique Mendez — 4 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Louisiana

Full comparison — all codes billed, vs. state median

28 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J1602	13	10	26,920	$10	$526.5K
J0129	9	10	9,490	$30	$506.1K
J3111	8	10	16,800	$10	$161.1K
J1306	5	10	13,350	$10	$109.4K
J0897	23	70	3,120	$20	$105.6K
96413	43	70	140	$90	$22.8K
93306	255	390	200	$90	$22.2K
99214	8	6,670	110	$80	$16.5K
99215	150	1,650	40	$110	$8.4K
99213	3,650	6,060	70	$50	$8.1K

Showing 1–10 of 28

Related Providers

Other providers that share a Tax Identification Number (TIN) with Enrique Mendez, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Ryan Olson	FL	Anatomic Pathology & Clinical Pathology Physician	$12.8M	$80
Charles Wykoff	TX	Ophthalmology Physician	$6.2M	$0
Matthew Benz	TX	Ophthalmology Physician	$5.7M	$0
David Brown	TX	Ophthalmology Physician	$5.7M	$0
Tien Wong	TX	Ophthalmology Physician	$4.5M	$0
Jay Wang	FL	Medical Oncology Physician	$4.5M	$0
Joseph Sedrak	TX	MOHS-Micrographic Surgery Physician	$4.4M	$0
Shanda Jackson	LA	Family Nurse Practitioner	$4M	$0
Ankoor Shah	TX	Ophthalmology Physician	$3.7M	$0
James Russo	LA	Radiation Oncology Physician	$3.5M	$0

Nearby Providers

Other providers in the same ZIP code as Enrique Mendez, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Calcasieu Urgent Care LLC	LA	Urgent Care Clinic/Center	$0	$39.5M
Resource Management Services, Inc. Of Southwest Louisiana	LA	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$20.7M
Southwest Louisiana Independence Center, Inc	LA	In Home Supportive Care Agency	$0	$14.4M
Christus Health Southwestern Louisiana	LA	General Acute Care Hospital	$0	$11.8M
Medical Resources & Guidance, Inc.	LA	Case Management Agency	$0	$10.3M
Direct Care, Inc.	LA	Developmentally Disabled Services Day Training Agency	$0	$10.1M
Calcasieu Emergency Group LLC	LA	Emergency Medicine Physician	$0	$7.4M
Vcphcs Vi, LLC	LA	Substance Use Disorder Rehabilitation Clinic/Center	$110.8K	$6.7M
Pediatric Cardiology Of Southwest Louisiana, LLC	LA	Pediatric Cardiology Physician	$0	$6.1M
1st Abundant Home Care, LLC	LA	Developmentally Disabled Services Day Training Agency	$0	$5.1M

Enrique Mendez — Billing Profile & Reimbursement Data

Sign up for Enrique Mendez — Billing Profile & Reimbursement Data policy alerts

Enrique Mendez — Billing Profile & Reimbursement Data

Sign up for Enrique Mendez — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References